COMPANY
Inquis Medical
Since the raise (Jan 12, 2026): 24 of 24 open jobs were first seen after it.
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Sr. Director of Operations | Menlo Park, CA | Oct 7, 2026 | Oct 9, 2026 |
| Group Manager, Strategic Marketing | Menlo Park, CA | Sep 15, 2026 | Oct 9, 2026 |
| Accounting Associate | Menlo Park, CA | Sep 8, 2026 | Oct 9, 2026 |
| District Sales Manager - Atlanta | Atlanta, GA | Sep 3, 2026 | Oct 9, 2026 |
| District Sales Manager - Houston | Houston, TX | Aug 31, 2026 | Oct 9, 2026 |
Raises and deals from press releases
- Raise Series C · $75M · announced Jan 12, 2026 Company release ↗
Source quote
- Jan 12, 2026 · Company release ↗
“MENLO PARK, Calif.–( BUSINESS WIRE )– Inquis Medical, Inc. , a privately held medical technology company dedicated to advancing mechanical thrombectomy for venous thromboembolic disease (“VTE”), today announced the closing of a $75 million Series C financing round”
- Jan 12, 2026 · Company release ↗
- Raise Series B · $40M · announced Oct 28, 2025 Company release ↗
Source quote
- Oct 28, 2025 · Company release ↗
“MENLO PARK, Calif.–( BUSINESS WIRE )– Inquis Medical , a pioneering medical technology company specializing in advanced thrombectomy systems, today announced the successful closure of its $40 million Series B financing round”
- Oct 28, 2025 · Company release ↗
Timeline
- Board tracked Radar started tracking this company’s job board (24 open jobs at last check). source ↗
- FDA FDA 510(k) clearance: Powered Aventus Thrombectomy System — K261105, Jul 27, 2026. Applicant at approval: Inquis Medical. source ↗
- FDA FDA 510(k) clearance: Aventus Thrombectomy System — K262030, Jul 15, 2026. Applicant at approval: Inquis Medical. source ↗
- FDA FDA 510(k) clearance: Aventus Introducer Sheath — K260091, Apr 13, 2026. Applicant at approval: Inquis Medical. source ↗
- FDA FDA 510(k) clearance: Aventus Thrombectomy System — K253925, Jan 15, 2026. Applicant at approval: Inquis Medical. source ↗
- Raise Private equity round — Series C: $75M (total, as published), announced Jan 12, 2026. Source: company's own press page. source ↗
- Raise Series C · $75M source ↗
- Raise Private equity round — Series B: $40M (total, as published), announced Oct 28, 2025. Source: company's own press page. source ↗
- Raise Series B · $40M source ↗
- FDA FDA 510(k) clearance: Aventus Thrombectomy System — K251189, Jun 13, 2025. Applicant at approval: Inquis Medical. source ↗
- FDA FDA 510(k) clearance: Aventus Thrombectomy System (IM-2100) — K250668, Mar 25, 2025. Applicant at approval: Inquis Medical. source ↗
- FDA FDA 510(k) clearance: Aventus Thrombectomy System — K250202, Feb 26, 2025. Applicant at approval: Inquis Medical. source ↗
Open jobs 24
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Sr. Director of Operations | Menlo Park, CA | Oct 7, 2026 | Oct 9, 2026 | Senior |
| Group Manager, Strategic Marketing | Menlo Park, CA | Sep 15, 2026 | Oct 9, 2026 | Senior |
| Accounting Associate | Menlo Park, CA | Sep 8, 2026 | Oct 9, 2026 | Mid |
| District Sales Manager - Atlanta | Atlanta, GA | Sep 3, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Houston | Houston, TX | Aug 31, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Chicago | Chicago, IL | Aug 31, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Las Vegas | Las Vegas, NV | Aug 31, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - New Orleans | New Orleans, LA | Aug 28, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Knoxville | Knoxville, TN | Aug 24, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - St Louis | St Louis, MO | Aug 12, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Seattle | Seattle, WA | Aug 12, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - San Diego | San Diego, CA | Aug 12, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Phoenix | Phoenix, AZ | Aug 12, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Orlando | Orlando, FL | Aug 12, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - NW Los Angeles | Los Angeles, CA | Aug 12, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Louisville | Louisville, KY | Aug 12, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Los Angeles | Los Angeles, CA | Aug 12, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Fresno | Fresno, CA | Aug 12, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Cincinnati | Cincinnati, OH | Aug 12, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Charleston | Charleston, SC | Aug 12, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Boston | Boston, MA | Aug 12, 2026 | Oct 9, 2026 | Senior |
| District Sales Manager - Jacksonville | Jacksonville, FL | Aug 12, 2026 | Oct 9, 2026 | Senior |
| Principal R&D Engineer | Menlo Park, CA | Aug 12, 2026 | Oct 9, 2026 | Senior |
| Marketing & Communications Manager | Menlo Park, CA | Aug 12, 2026 | Oct 9, 2026 | Mid |
Funding
FDA records (last 2 years)
- FDA 510(k) clearance: Powered Aventus Thrombectomy System — K261105, Jul 27, 2026. Applicant at approval: Inquis Medical. source ↗
- FDA 510(k) clearance: Aventus Thrombectomy System — K262030, Jul 15, 2026. Applicant at approval: Inquis Medical. source ↗
- FDA 510(k) clearance: Aventus Introducer Sheath — K260091, Apr 13, 2026. Applicant at approval: Inquis Medical. source ↗
- FDA 510(k) clearance: Aventus Thrombectomy System — K253925, Jan 15, 2026. Applicant at approval: Inquis Medical. source ↗
- FDA 510(k) clearance: Aventus Thrombectomy System — K251189, Jun 13, 2025. Applicant at approval: Inquis Medical. source ↗
- FDA 510(k) clearance: Aventus Thrombectomy System (IM-2100) — K250668, Mar 25, 2025. Applicant at approval: Inquis Medical. source ↗
- FDA 510(k) clearance: Aventus Thrombectomy System — K250202, Feb 26, 2025. Applicant at approval: Inquis Medical. source ↗
Connect
See your connections at Inquis Medical on LinkedIn (search by name, results not checked)